Excipients

Apr 01, 2011
Pharmaceutical Technology
By Pharmaceutical Technology Editors
The author describes key considertions for a complete risk-assessment model and provides insight into a pending IPEC guideline in this area.
Apr 01, 2011
Pharmaceutical Technology
By Pharmaceutical Technology Editors
The author focuses on how industry can build a system for Total Excipient Control.
Apr 01, 2011
Pharmaceutical Technology
This technical forum is part of a special issue on Solid Dosage and Excipients.
Mar 02, 2011
Pharmaceutical Technology
By Pharmaceutical Technology Editors
A new audit guide aims to improve supply-chain security and supplier qualification practice.
Mar 02, 2011
Pharmaceutical Technology
By Pharmaceutical Technology Editors
The authors investigated the tableting properties of PanExcea MHC300G, a high-performance excipient.
Jan 07, 2011
Pharmaceutical Technology Europe
By Pharmaceutical Technology Editors
Excipients should be regulated to manage risk. Although, excipients are an integral part of a finished pharmaceutical product, the issue of regulation is complex.
Jan 07, 2011
Pharmaceutical Technology Europe
By Pharmaceutical Technology Editors
Biologics are large molecular weight molecules primarily formulated for parenteral administration; however, there are some smaller biomolecules that have been formulated for oral use.
Jan 07, 2011
Pharmaceutical Technology Europe
By Pharmaceutical Technology Editors
Iain Moore explains what progress has been made so far regarding EU plans to regulate excipients.
Jan 07, 2011
Pharmaceutical Technology Europe
By Pharmaceutical Technology Editors
During the past few years, we've seen a growing interest in direct oral application products, evidenced by the large amount of products already available on the market.
Jan 01, 2011
Pharmaceutical Technology Europe
By Pharmaceutical Technology Editors
Excipient purity is critical in all applications of drug formulation. Typically, the more sensitive or reactive an API, the more critical excipient purity becomes.
native1_300x100
lorem ipsum